Spruce Biosciences, Inc. · NASDAQ:SPRB
Orbimed Advisors LLC reported a 4.80% stake in Spruce Biosciences, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Orbimed Advisors LLC reported a 4.80% stake in Spruce Biosciences, Inc., 132,200 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 4.80%
- Shares
- 132,200
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 4.80% | 132,200 |
| OrbiMed Capital LLC | 2.50% | 67,800 |
Source
Related
- Spruce Biosciences, Inc.
- Orbimed Advisors LLC
- Spruce Biosciences, Inc. shareholders
- Schedule 13G · AWM Investment Company, Inc. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 4, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026